{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:55:22Z","timestamp":1782320122475,"version":"3.54.5"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ticks and Tick-borne Diseases"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ttbdis.2021.101779","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T06:40:18Z","timestamp":1626158418000},"page":"101779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Can the booster interval for the tick-borne encephalitis (TBE) vaccine \u2018FSME-IMMUN\u2019 be prolonged? \u2014 A systematic review"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7917-1141","authenticated-orcid":false,"given":"R","family":"Steffen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Erber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HJ","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ttbdis.2021.101779_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140545","article-title":"Human CD4+ T helper cell responses after tick-borne encephalitis vaccination and infection","volume":"10","author":"Aberle","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0002","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11357-011-9371-9","article-title":"Mechanistic insights into the impairment of memory B cells and antibody production in the elderly","volume":"35","author":"Aberle","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0003","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/vbz.2018.2359","article-title":"Comparison of Four Commercial IgG-enzyme-linked immunosorbent assays for the detection of tick-borne encephalitis virus antibodies","volume":"19","author":"Ackermann-Gaumann","year":"2019","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0004","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00365540110027358","article-title":"Pharmacokinetics of human tick-borne encephalitis virus antibody levels after injection with human tick-borne encephalitis immunoglobulin, solvent\/detergent treated, FSME-BULIN S\/D in healthy volunteers","volume":"33","author":"Adner","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0005","doi-asserted-by":"crossref","first-page":"tav020","DOI":"10.1093\/jtm\/tav020","article-title":"Analysis of delayed TBE-vaccine booster after primary vaccination","volume":"23","author":"Aerssens","year":"2016","journal-title":"J. Travel Med."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0006","article-title":"Antibody responses to tick-borne encephalitis virus non-structural protein 1 and whole virus antigen-a new tool in the assessment of suspected vaccine failure patients","volume":"9","author":"Albinsson","year":"2019","journal-title":"Infect. Ecol. Epidemiol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0007","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0008","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.vaccine.2011.11.061","article-title":"Immunogenicity of delayed TBE-vaccine booster","volume":"30","author":"Askling","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0009","first-page":"225","article-title":"Empfehlungen zur Impfung gegen Zeckenenzephalitis","volume":"13","year":"2006","journal-title":"Bulletin BAG"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0010","first-page":"13","article-title":"Durchimpfung von 2-, 8- und 16-j\u00e4hrigen Kindern in der Schweiz, 2014-2016","volume":"24","year":"2018","journal-title":"Bulletin BAG"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0011","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/jmv.23313","article-title":"Persistence of immunity to tick-borne encephalitis after vaccination and natural infection","volume":"84","author":"Baldovin","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2020.10.022","article-title":"Analysis of Tick-borne Encephalitis vaccination coverage and compliance in adults in Switzerland, 2018\u2032","author":"Baroutsou","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0013","first-page":"23","article-title":"Tick-borne encephalitis in Europe, 2012 to 2016\u2032","author":"Beaute","year":"2018","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0014","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00415-004-0329-z","article-title":"Two severe cases of tick-borne encephalitis despite complete active vaccination\u2013the significance of neutralizing antibodies\u2019","volume":"251","author":"Bender","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0015","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2017.12.081","article-title":"Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10years antibody persistence","volume":"37","author":"Beran","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0016","first-page":"375","article-title":"Immunogenicity of a booster vaccination against tick-borne encephalitis","volume":"85","author":"Beskovnik","year":"2016","journal-title":"Zdrav. Vestn."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0017","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1080\/21645515.2019.1700712","article-title":"Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules","volume":"16","author":"Costantini","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1090","key":"10.1016\/j.ttbdis.2021.101779_bib0018","first-page":"e7","article-title":"Tick-borne encephalitis virus vaccination breakthrough infections in Germany: a retrospective analysis from 2001 to 2018\u2032","volume":"26","author":"Dobler","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0019","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF01716097","article-title":"Diagnosis of tick-borne encephalitis: evaluation of sera with borderline titers with the TBE-ELISA","volume":"24","author":"Dobler","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0020","series-title":"ECDC. Annual epidemiological report for 2018 (ECDC: Stockholm)","article-title":"Tick-borne encephalitis","year":"2019"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0021","doi-asserted-by":"crossref","first-page":"e56974","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic vaccination response after solid organ transplantation: a systematic review","volume":"8","author":"Eckerle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0022","unstructured":"EMA. 'Guideline on clinical evaluation of vaccines. Draft. EMEA\/CHMP\/VWP\/164653\/05 Rev.1. 26 April 2018. ', Accessed 8 September. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-clinical-evaluation-vaccines-revision-1_en.pdf."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0023","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ttbdis.2018.02.007","article-title":"Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study","volume":"9","author":"Erber","year":"2018","journal-title":"Ticks Tick Borne Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0024","first-page":"8","article-title":"Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination","author":"Feige","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0027","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/14760584.2017.1358620","article-title":"Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules","volume":"16","author":"Galgani","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0028","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3389\/fimmu.2020.00860","article-title":"Obesity and sex affect the immune responses to tick-borne encephalitis booster vaccination","volume":"11","author":"Garner-Spitzer","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0029","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2018.03.076","article-title":"Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias","volume":"36","author":"Garner-Spitzer","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0030","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.4049\/jimmunol.1300293","article-title":"Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10","volume":"191","author":"Garner-Spitzer","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0031","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1016\/j.vaccine.2010.09.003","article-title":"Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis","volume":"28","author":"Grgic-Vitek","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0032","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0033","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/cid\/ciz176","article-title":"Tick-borne Encephalitis Vaccine Failures: a 10-year Retrospective Study Supporting the Rationale for Adding an Extra Priming Dose in Individuals Starting at Age 50 Years","volume":"70","author":"Hansson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006643","article-title":"A novel mechanism of antibody-mediated enhancement of flavivirus infection","volume":"13","author":"Haslwanter","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0035","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0036","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0037","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid1901.120458","article-title":"Vaccination and tick-borne encephalitis, central Europe","volume":"19","author":"Heinz","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8020042","article-title":"Epidemiology of Tick-Borne Encephalitis (TBE) in Germany, 2001\u207b2018","volume":"8","author":"Hellenbrand","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0039","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.vaccine.2015.12.029","article-title":"Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study","volume":"34","author":"Hertzell","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0040","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/jvi.64.10.5156-5159.1990","article-title":"A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model","volume":"64","author":"Holzmann","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0041","doi-asserted-by":"crossref","unstructured":"Hombach, J., Barrett, A.D.T., Kollaritsch, H. 2018. 'Tickborne encephalitis vaccines.' in Orenstein WA Plotkin SA, Offit PA, Edwards KM (ed.), Plotkin's Vaccines, 7th edition (Elsevier: Philadelphia, PA).","DOI":"10.1016\/B978-0-323-35761-6.00059-6"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0042","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cmi.2017.01.012","article-title":"Compliance with vaccination against tick-borne encephalitis virus in Germany","volume":"23","author":"Jacob","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0043","first-page":"56","article-title":"Analysis of Multiple Risk Factors for Seronegative Rate of Anti-Tick-Borne Encephalitis Virus Immunization in Human Serum","author":"Janik","year":"2020","journal-title":"Medicina (Kaunas)."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0044","doi-asserted-by":"crossref","first-page":"13845","DOI":"10.1128\/JVI.02086-14","article-title":"Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination","volume":"88","author":"Jarmer","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712590903066711","article-title":"Serological response to tick-borne encephalitis (TBE) vaccination in the elderly\u2013results from an observational study\u2019","volume":"9","author":"Jilkova","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0046","first-page":"542","article-title":"Impfung gegen FSME \u2014 Fraglicher Nutzen der Antik\u00f6rperbestimmung zur \u00dcberpr\u00fcfung der Immunit\u00e4tslage\u2019","volume":"124","author":"Kaiser","year":"1999","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"Pt 11","key":"10.1016\/j.ttbdis.2021.101779_bib0047","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0049","first-page":"877","article-title":"Problems of cut-off level determination in enzyme immunoassays: the case of TBE-ELISA","volume":"39","author":"Kiessig","year":"1993","journal-title":"Klin. Lab"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4414\/saez.2004.10416","article-title":"Wie viele Auffrischimpfungen sind notwendig gegen die Zeckenenzephalitis FSME","volume":"85","author":"Kind","year":"2004","journal-title":"Schweizerische \u00c4rztezeitung"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0051","first-page":"231","article-title":"Erfahrungen mit Titermessungen zur Impfschutzkontrolle bei der Zeckenenzephalitis FSME","volume":"5","author":"Kind","year":"2005","journal-title":"Primary Care"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0052","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-2007-1004536","article-title":"Tick-borne encephalitis (TBE) \u2014 antibody titers and long term immunity\u2019","volume":"84","author":"Kind","year":"2008","journal-title":"Z. Allg. Med."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0053","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jiq082","article-title":"A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection","volume":"203","author":"Kindberg","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0054","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s15010-006-6614-2","article-title":"Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination","volume":"35","author":"Kleiter","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0055","first-page":"26","article-title":"Revised recommendations for rabies pre-exposure prophylaxis in travellers: avoid bumpy roads, select the highway!\u2019","author":"Knopf","year":"2019","journal-title":"J. Travel Med."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0056","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/erv.12.86","article-title":"Vaccines and vaccination against tick-borne encephalitis","volume":"11","author":"Kollaritsch","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0057","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2017.03.059","article-title":"Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults","volume":"35","author":"Konior","year":"2017","journal-title":"Vaccine"},{"issue":"506","key":"10.1016\/j.ttbdis.2021.101779_bib0058","first-page":"08","article-title":"[Fatal outcome of tick-borne encephalitis despite complete active vaccination]","volume":"82","author":"Koppi","year":"2011","journal-title":"Nervenarzt"},{"issue":"Suppl 1","key":"10.1016\/j.ttbdis.2021.101779_bib0059","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0060","first-page":"273","article-title":"Die FSME-Impfung, eine Massnahme der Vorsorgemedizin mit hoher Akzeptanz in \u00d6sterreich","volume":"12","author":"Kunz","year":"1991","journal-title":"Wiener Med. Woschr"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2019.101287","article-title":"Report of the 21st Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE): TBE - record year 2018","volume":"11","author":"Kunze","year":"2020","journal-title":"Ticks Tick Borne Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0062","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ttbdis.2018.02.021","article-title":"Clinical outcome and cerebrospinal fluid profiles in patients with tick-borne encephalitis and prior vaccination history","volume":"9","author":"Lenhard","year":"2018","journal-title":"Ticks Tick Borne Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100860","article-title":"Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals","volume":"9","author":"Lindblom","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0064","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2011.07.089","article-title":"Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme","volume":"29","author":"Loew-Baselli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4161\/hv.5.8.8571","article-title":"Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years","volume":"5","author":"Loew-Baselli","year":"2009","journal-title":"Hum. Vaccin."},{"issue":"Suppl 1","key":"10.1016\/j.ttbdis.2021.101779_bib0066","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijmm.2008.03.006","article-title":"Tick-borne encephalitis after active immunization\u2019","volume":"298","author":"Lotric-Furlan","year":"2008","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0067","article-title":"Tick-borne encephalitis in patients vaccinated against this disease","author":"Lotric-Furlan","year":"2017","journal-title":"J. Intern. Med."},{"issue":"264\u20139","key":"10.1016\/j.ttbdis.2021.101779_bib0068","first-page":"W64","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0069","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.vaccine.2014.02.046","article-title":"Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus","volume":"32","author":"Morozova","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002028","article-title":"Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study","volume":"13","author":"Page","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0071","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.vaccine.2012.12.075","article-title":"Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination","volume":"31","author":"Paulke-Korinek","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0072","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1016\/j.vaccine.2009.09.068","article-title":"Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection","volume":"27","author":"Paulke-Korinek","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0073","first-page":"17","article-title":"[Dynamics of antibody formation after vaccination against tick-borne encephalitis]","volume":"53","author":"Pazdiora","year":"2004","journal-title":"Epidemiol. Mikrobiol. Imunol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0074","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.vaccine.2007.11.009","article-title":"TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area\u2013impact on current recommendations for immunization of high-risk groups\u2019","volume":"26","author":"Plisek","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0075","doi-asserted-by":"crossref","unstructured":"Plotkin SA, Gilbert P. 2018. 'Correlates of protection.' in Orenstein WA Plotkin SA, Offit PA, Edwards KM (ed.), Plotkin's Vaccines, 7th edition (Elsevier: Philadelphia, PA).","DOI":"10.1016\/B978-0-323-35761-6.00003-1"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2019.03.032","article-title":"Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults","author":"Poellabauer","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0077","unstructured":"PROGEN. 2016. 'Immunozym FSME IgG all species. Date of release 2016-04-28.', Accessed 21 July. https:\/\/www.progen.com\/media\/downloads\/descriptions\/7701075_en_V15.pdf."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101876","article-title":"Immunogenicity and safety of the tick-borne encephalitis vaccination (2009-2019): a systematic review","volume":"37","author":"Rampa","year":"2020","journal-title":"Travel. Med. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftu002","article-title":"Anti-tick-borne encephalitis (TBE) virus neutralizing antibodies dynamics in natural infections versus vaccination","volume":"73","author":"Remoli","year":"2015","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0080","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.vaccine.2004.01.041","article-title":"Persistence of protective immunity following vaccination against tick-borne encephalitis\u2013longer than expected?","volume":"22","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0081","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vaccine.2004.07.002","article-title":"Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation","volume":"23","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl 40","key":"10.1016\/j.ttbdis.2021.101779_bib0082","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijmm.2006.01.030","article-title":"Persistence of antibodies after vaccination against tick-borne encephalitis\u2019","volume":"296","author":"Rendi-Wagner","year":"2006","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0083","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1016\/j.vaccine.2007.01.116","article-title":"Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up","volume":"25","author":"Rendi-Wagner","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0084","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","article-title":"Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines","volume":"164","author":"Ruzek","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0085","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.vaccine.2014.01.072","article-title":"Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study","volume":"32","author":"Schosser","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0086","first-page":"19","article-title":"Epidemiology of tick-borne encephalitis in Switzerland, 2005 to 2011","author":"Schuler","year":"2014","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0087","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fneur.2017.00119","article-title":"Fatal outcome of European tick-borne encephalitis after vaccine failure","volume":"8","author":"Sendi","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0088","unstructured":"Siegrist, C.A.2018. 'Vaccine immunology.' in Orenstein WA Plotkin SA, Offit PA, Edwards KM (ed.), Plotkin's Vaccines, 7th edition (Elsevier: Philadelphia, PA)."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0089","doi-asserted-by":"crossref","first-page":"e34145","DOI":"10.1371\/journal.pone.0034145","article-title":"Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis","volume":"7","author":"Stiasny","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0090","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1016\/j.vaccine.2009.09.069","article-title":"Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs","volume":"27","author":"Stiasny","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0091","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2006.07.026","article-title":"Study of the serological response after vaccination against tick-borne encephalitis in Sweden","volume":"25","author":"Vene","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0092","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14276","article-title":"Patients with breakthrough tick-borne encephalitis suffer a more severe clinical course and display extensive MRI changes","author":"Wagner","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0093","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.vaccine.2010.03.024","article-title":"Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years","volume":"28","author":"Weinberger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0094","first-page":"241","article-title":"Vaccines against tick-borne encephalitis: WHO position paper","volume":"86","year":"2011","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0095","series-title":"'Expert Consultation on Rabies, third report.","first-page":"2018","year":"2018"},{"key":"10.1016\/j.ttbdis.2021.101779_bib0096","unstructured":"WHO, 2018b. 'Rabies vaccines: WHO position paper, April 2018 - Recommendations'."},{"key":"10.1016\/j.ttbdis.2021.101779_bib0097","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204844","article-title":"Tick-borne encephalitis: A 43-year summary of epidemiological and clinical data from Latvia (1973 to 2016)","volume":"13","author":"Zavadska","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ttbdis.2021.101779_bib0098","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-020-01943-w","article-title":"The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection","volume":"17","author":"Lindqvist","year":"2020","journal-title":"J. Neuroinfammation."}],"container-title":["Ticks and Tick-borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X21001321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X21001321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T07:03:26Z","timestamp":1627628606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877959X21001321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1877959X21001321"],"URL":"https:\/\/doi.org\/10.1016\/j.ttbdis.2021.101779","relation":{},"ISSN":["1877-959X"],"issn-type":[{"value":"1877-959X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can the booster interval for the tick-borne encephalitis (TBE) vaccine \u2018FSME-IMMUN\u2019 be prolonged? \u2014 A systematic review","name":"articletitle","label":"Article Title"},{"value":"Ticks and Tick-borne Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ttbdis.2021.101779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101779"}}